ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.839,46
2,44%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) News

BNTX

BioNTech (BNTX)

BioNTech SE
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
17/05/202417h15GlobeNewswire Inc.BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024NASDAQ:BNTXBioNTech SE
06/05/202414h09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:BNTXBioNTech SE
06/05/202413h18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
06/05/202412h48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
06/05/202412h45GlobeNewswire Inc.BioNTech Announces First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNASDAQ:BNTXBioNTech SE
24/04/202413h28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNASDAQ:BNTXBioNTech SE
22/04/202412h45GlobeNewswire Inc.BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024NASDAQ:BNTXBioNTech SE
07/04/202420h00GlobeNewswire Inc.Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic CancerNASDAQ:BNTXBioNTech SE
21/03/202412h17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNASDAQ:BNTXBioNTech SE
20/03/202412h17IH Market NewsU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices DipNASDAQ:BNTXBioNTech SE
20/03/202411h15GlobeNewswire Inc.BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
20/03/202411h00GlobeNewswire Inc.BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial OfficerNASDAQ:BNTXBioNTech SE
11/03/202414h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
11/03/202412h45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024NASDAQ:BNTXBioNTech SE
11/03/202411h25PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTXNASDAQ:BNTXBioNTech SE
07/03/202414h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
07/03/202412h45GlobeNewswire Inc.BioNTech Announces Planned Retirement of Sean MarettNASDAQ:BNTXBioNTech SE
06/03/202412h45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024NASDAQ:BNTXBioNTech SE
05/03/202411h45PR Newswire (US)The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTXNASDAQ:BNTXBioNTech SE
29/02/202400h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
26/02/202411h45PR Newswire (US)Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BNTXBioNTech SE
22/02/202411h45PR Newswire (US)BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTXNASDAQ:BNTXBioNTech SE
15/02/202422h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTXBioNTech SE
15/02/202411h00PR Newswire (US)Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BNTXBioNTech SE
14/02/202413h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BNTXBioNTech SE
09/02/202411h45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) ShareholdersNASDAQ:BNTXBioNTech SE
08/02/202412h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
08/02/202411h45GlobeNewswire Inc.BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs  NASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX

Kürzlich von Ihnen besucht

ASX
GSBE47
Australia Government
EU
ORDI
Ordina NV
UNSW3
ONXETH
OnX.finance
BOV
YBRA3
Ybyra Capital S.A ON
UPBT
GASKRW
NEO Gas
ASX
KIKRB
NASDAQ
ABOS
Acumen Pharmaceuticals
LSE
VT23
Export.fin.27.a
BOV
SLCE3R
SLC AGRICOLA ON
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten